Corteva Halts Production of Controversial Herbicide Amid Environmental Concerns

Emily Watson, Health Editor
4 Min Read
⏱️ 3 min read

Corteva, a leading American agricultural chemical company, has announced it will cease production of Enlist Duo, a herbicide that has faced significant criticism for its toxic composition, which combines elements of Agent Orange and glyphosate. This decision marks a significant victory for environmental advocates who have campaigned for years against the use of this harmful chemical mixture.

A Toxic Legacy

Enlist Duo has been controversial since its inception, as it incorporates 2,4-D, a component originally used in Agent Orange, the defoliant deployed during the Vietnam War, alongside glyphosate, a widely debated herbicide. Both substances have been implicated in severe health risks, including cancer, and have raised alarms due to their potential ecological impact. The US Environmental Protection Agency (EPA) has approved Enlist Duo for use on food crops, despite these concerns, allowing its application on approximately 4.5 million acres of corn, soybeans, and genetically modified cotton annually.

Environmentalists have long condemned this herbicide, labelling it a ‘toxic cocktail’ and arguing against its safety for both human health and biodiversity. Kristina Sinclair, a staff attorney with the Centre for Food Safety (CFS), expressed relief at Corteva’s decision, stating, “Our food system never should have been doused in this toxic cocktail, and now never will be again.”

Corteva’s decision comes after a decade marked by litigation and public advocacy aimed at banning Enlist Duo. Sinclair highlighted the significance of this announcement, stating that the company opted to withdraw the product rather than contest the legal arguments presented. In 2020, a federal court invalidated the EPA’s approval of Enlist Duo, yet the agency reapproved it in 2022, a decision that many advocates believe was made without adequate consideration of its environmental consequences.

Despite the discontinuation of Enlist Duo, the company will continue to produce Enlist One, which contains 2,4-D. This herbicide is still at the centre of ongoing legal scrutiny, as critics maintain that its approval poses risks to both public health and endangered species.

Health and Environmental Risks

The World Health Organization has classified 2,4-D as a ‘possible’ carcinogen, linking it to serious health conditions such as non-Hodgkin lymphoma, respiratory issues, and reproductive harm. Furthermore, it poses threats to numerous endangered species, including various butterflies, birds, and fish. The CFS’s legal filings argue that the use of 2,4-D could exacerbate the emergence of herbicide-resistant weeds, creating a cycle of dependency on more potent chemicals that farmers must tackle.

Nathan Donley, environmental health director with the Centre for Biological Diversity, commented on the ongoing challenges with the EPA, stating that the agency often prioritises the swift approval of pesticides over thorough evaluations of their safety.

Implications for the Future

Corteva’s withdrawal of Enlist Duo is a pivotal moment in the ongoing discourse surrounding agricultural chemicals and their regulation. While the decision reflects a growing recognition of the potential dangers of such herbicides, the continuation of products like Enlist One suggests that the struggle for safer agricultural practices is far from over.

Why it Matters

The halt in production of Enlist Duo highlights the critical intersection of public health, environmental activism, and regulatory oversight. As awareness grows about the potential dangers of certain agricultural chemicals, this decision could signal a shift in how such products are viewed and regulated. It underscores the power of public advocacy and legal action in shaping agricultural policies, reminding us that our food systems must prioritise safety and sustainability over convenience and profit.

Share This Article
Emily Watson is an experienced health editor who has spent over a decade reporting on the NHS, public health policy, and medical breakthroughs. She led coverage of the COVID-19 pandemic and has developed deep expertise in healthcare systems and pharmaceutical regulation. Before joining The Update Desk, she was health correspondent for BBC News Online.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2026 The Update Desk. All rights reserved.
Terms of Service Privacy Policy